If you have osteoporosis or have a risk for bone loss, your doctor might suggest Prolia (denosumab) as a treatment option for you. Prolia is a prescription medication that treats osteoporosis and ...
A blockbuster Amgen drug for osteoporosis now carries the FDA’s strictest warning that its use can lead to dangerously low levels of calcium in the blood. This complication, hypocalcemia, is a ...
Prolia is administered as a single subcutaneous injection of 60 mg once every six months. Please see the Important Safety Information below. EU Important EU Product Information Calcium and Vitamin D ...
Prolia is also indicated as a treatment to increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer and in men at high risk for fracture ...
On-time osteoporosis treatments are vital for reaping their full prevention benefits, according to a new study. In a study of 2,594 adults initiating denosumab for non-cancer indications (Prolia), ...
--Amgen today announced new data from a real-world study of nearly half of a million postmenopausal women with osteoporosis in the U.S. medicare program showing Prolia ® injection reduced fracture ...
Subjects treated for 10 years with denosumab achieved an average cumulative 10-year gain in BMD of 21.7 percent at the lumbar spine and 9.2 percent at the total hip, compared to baseline in the ...
THOUSAND OAKS, Calif., June 1, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced results from a randomized, double-blind, placebo-controlled, multicenter Phase 3 study evaluating the treatment ...
Prolia should be covered by Medicare Part A, Part B, or Part D, depending on why you need to take the drug and whether you will administer it yourself. Prolia (denosumab) is an injectable monoclonal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results